Details for Patent: 9,675,611

Summary for Patent: 9,675,611

Title:	Methods of providing analgesia
Abstract:	A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C.sub.12/C.sub.max ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.
Inventor(s):	Oshlack; Benjamin (Boca Raton, FL), Huang; Hua-Pin (Englewood Cliffs, NJ), Masselink; John (Old Tappan, NJ), Tonelli; Alfred (Congers, NY)
Assignee:	Purdue Pharma L.P. (Stamford, CT)
Application Number:	15/376,851
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,675,611
Patent Claim Types: see list of patent claims	Use; Formulation; Delivery; Dosage form;

Drugs Protected by US Patent 9,675,611

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 9,675,611

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	526950
Australia	1446501
Australia	2003262463